This module covers the role of patient quality of life in cancer research and treatment, and explores approaches for improving quality of life.
Quality of Life (QoL)
Univadis Oncology eLearning
1. WHOQOL SRPB Group: A cross-cultural study of spirituality, religion, and personal beliefs as components of quality of life. Social Science & Medicine (2006). 62: 1486-1497. doi:10.1016/j.socscimed.2005.08.001
2. M. Bullinger et al: Methoden zur Lebensqualitätsbewertung, in: R. Hartenstein, U. R. Kleeberg: Schmerztherapie, in: H.-J. Schmoll. K. Höffken, K. Possinger (Hrsg.): Kompendium Internistische Onkologie, Springer Verlag 2006, S. 2505-2516
3. Zimmermann C et al; Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial; Lancet (2014), 383 (9930): 1721-1730
4. Department of Health; Quality of life of cancer survivors in England: Report on a pilot survey using Patient Reported Outcome Measures (PROMS); (2012); https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/267042/9284-TSO-2900701-PROMS-1.pdf
5. Sammarco A et al; Comparison of QOL in Younger and Older Breast Cancer Survivors; Cancer Nursing (2009); 32 (5): 347-356
6. Ernst J et al; Quality of life of parents diagnosed with cancer: change over time and influencing factors; European Journal of Cancer Care (2012); 21: 535-541
8. Bergner, M., Bobbitt, R.A., Carter, W.B., & Gilson, B.S. (1981). The Sickness Impact Profile: development and final revision of a health status measure. Medical Care, 19(8), 787-805, Available online at: http://www.oandplibrary.org/poi/images/1994_01_018/1994_01_018_RAW-5.jpg
9. Aaronson et al. Journal of the National Cancer Institute Vol85, nº 5. March 3 1993 https://www.clinicalresearch.nl/portec3/Quality_of_life_questionnaire_PORTEC3_Deutsch.pdf
10. Chow, Edward, MBBS; Merrick, Joav, MD, MMedSc, DMSc. Journal of Pain Management6.2 (2013): 1-2.
Responsible for the content: © 2015 KWHC GmbH, Alewinstr. 13, 29525 Uelzen (Germany). The image sources can be found at: http://www.kwhc.de/webpage/index.php/oncology-nurses-copyrights.html
50mins - Expert presentations By Centers for Disease Control and Prevention
Zika Virus—What Clinicians Need to Know
Experts from the CDC present a comprehensive overview: Zika Virus-What Clinicians Need to Know, and provide responses to selected questions
9mins - Expert presentations By Vicky Tittle
Dr Vicky Tittle, from 56 Dean Street in London, UK, reviews the reasons to test for HIV, when and how to test and which key populations should receive testing. Specific focus is placed on British guidelines for HIV testing and importance to conduct key initial investigations.
13mins - Expert presentations By Professor David Livermore
Future developments in antimicrobial agents
Professor David Livermore highlights increasing resistance and the major bacterial challenges we face. Beta-lactams, the most widely used antibiotic are losing their efficacy. However, there is hope for antimicorbial agents. Cefiderocol, murepavadin and gepotidacin/zoliflodacin all show promise in replacing spent antibiotics. Further, non-antibiotic approaches and improved molecular diagnostics, while not currently comprehensive, could revolutionise the field.